Capital Advisory Group Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-36
Closed -$5K 276
2022
Q1
$5K Buy
+36
New +$5.02K ﹤0.01% 429
2021
Q4
Sell
-4,320
Closed -$628K 250
2021
Q3
$628K Buy
4,320
+61
+1% +$8.93K 0.23% 101
2021
Q2
$562K Sell
4,259
-3,573
-46% -$468K 0.2% 108
2021
Q1
$1M Buy
+7,832
New +$965K 0.39% 71

Other funds holding DGX

Capital Advisory Group Advisory Services's DGX Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 36 shares — an estimated $5K sold.

Capital Advisory Group Advisory Services first reported a position in DGX in Q1 2021 and held it in 4 quarters. The position peaked at $1M in Q1 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Capital Advisory Group Advisory Services reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 36 Quest Diagnostics shares in Q2 2022, an estimated $5K.
  • Capital Advisory Group Advisory Services first reported a position in Quest Diagnostics in Q1 2021 and held it in 4 quarters.
  • Capital Advisory Group Advisory Services's Quest Diagnostics position peaked at $1M in Q1 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.